Search for: "Smithkline Beecham Pharmaceutical Co." Results 81 - 87 of 87
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jun 2014, 12:57 pm by Schachtman
Ortho Pharmaceutical Corp., 788 F. 2d 741, 744–745 (11th Cir. 1986). [read post]
4 Mar 2012, 9:02 am by Schachtman
Merrill Dow Pharmaceuticals, Inc., 874 F.2d 307, 311-12 (5th Cir. 1989)(“Fortunately, we do not have to resolve any of the above questions [as to bias and confounding], since the studies presented to us incorporate the possibility of these factors by the use of a confidence interval. [read post]
19 Sep 2008, 6:00 pm
: (Spicy IP), India: Supreme Court on exclusive marketing rights: (Spicy IP), Japan: First induced pluripotent stem (iPS) cell patent at Kyoto University: (Competitive Info), Slovenia: Supplementary protection certificates in Slovenia: (The SPC Blog), United States: Biotech/pharma lobbying scoreboard – second quarter update – part II: (Patent Docs), United States: Ferring Pharmaceuticals argues to bring down direct purchaser suits: (Law 360), United States: Transferred… [read post]
5 Aug 2021, 12:12 pm by Lawrence B. Ebert
The outcome was a vacating of the district court's grant of JMOL and a lot of discussion of drug "skinny labels": GlaxoSmithKline LLC and SmithKline Beecham (Cork) Ltd. [read post]
20 Oct 2018, 8:50 am by Schachtman
One of the challenges of epidemiologic research is selecting the right outcome of interest to study. [read post]
24 Dec 2015, 4:00 am by Administrator
Each Thursday we present a significant excerpt, usually from a recently published book or journal article. [read post]